A new trading day began on Tuesday, with Organogenesis Holdings Inc (NASDAQ: ORGO) stock price up 8.94% from the previous day of trading, before settling in for the closing price of $4.25. ORGO’s price has ranged from $2.28 to $6.71 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 754.67%. With a float of $64.15 million, this company’s outstanding shares have now reached $126.85 million.
The extent of productivity of a business whose workforce counts for 869 workers is very important to gauge. In terms of profitability, gross margin is 74.89%, operating margin of -5.27%, and the pretax margin is -5.29%.
Organogenesis Holdings Inc (ORGO) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Organogenesis Holdings Inc is 49.43%, while institutional ownership is 51.46%. The most recent insider transaction that took place on Jun 05 ’25, was worth 413,625. In this transaction Chief Admin. and Legal Officer of this company bought 142,379 shares at a rate of $2.91, taking the stock ownership to the 837,437 shares. Before that another transaction happened on Jun 04 ’25, when Company’s Chief Admin. and Legal Officer bought 100,863 for $2.82, making the entire transaction worth $284,716. This insider now owns 695,058 shares in total.
Organogenesis Holdings Inc (ORGO) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 754.67% per share during the next fiscal year.
Organogenesis Holdings Inc (NASDAQ: ORGO) Trading Performance Indicators
Here are Organogenesis Holdings Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.67. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.28.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.15, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach 0.20 in one year’s time.
Technical Analysis of Organogenesis Holdings Inc (ORGO)
The latest stats from [Organogenesis Holdings Inc, ORGO] show that its last 5-days average volume of 0.93 million was inferior to 1.6 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 97.03%.
During the past 100 days, Organogenesis Holdings Inc’s (ORGO) raw stochastic average was set at 49.27%, which indicates a significant decrease from 99.04% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.22 in the past 14 days, which was lower than the 0.31 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.62, while its 200-day Moving Average is $3.67. Now, the first resistance to watch is $4.76. This is followed by the second major resistance level at $4.89. The third major resistance level sits at $5.13. If the price goes on to break the first support level at $4.39, it is likely to go to the next support level at $4.15. The third support level lies at $4.02 if the price breaches the second support level.
Organogenesis Holdings Inc (NASDAQ: ORGO) Key Stats
With a market capitalization of 587.33 million, the company has a total of 126,854K Shares Outstanding. Currently, annual sales are 482,040 K while annual income is 860 K. The company’s previous quarter sales were 86,690 K while its latest quarter income was -18,840 K.
